OpusPoint Partners: Preparing for a New Approach to Life Science and Healthcare
OpusPoint Partners envisions a world with greater commitment to better medicine and healthcare. They intend to be at the forefront of this new wave of revolutionized healthcare by making strong investments of time and money in the newest innovations. With the progressive development of life science and healthcare, mankind will achieve a brighter future that is healthier for everyone.
OpusPoint Partners, founded in 2009, is only one of the biotech companies established by Michael S. Weiss and Dr. Lindsay Rosenwald. The two men have over 40 years of experience between them in life sciences and biotech investment. They both have a strong passion for the field of biotechnology.
Cougar Biotechnology Inc. is another company founded by Dr. Lindsay Rosenwald. The company is based in Los Angeles and focuses on experimental drug research for cancer. Cougar has gained some attention from researchers and investors impressed by some of its more remarkable developments of experimental drugs. One such drug has shown promise in the treatment of late-stage prostate cancer. For about one billion dollars, Cougar Biotech Labs was acquired by Johnson & Johnson on July 10, 2009.
OpusPoint Partners and Lindsay Rosenwald are committed to maintaining strong business associations with the biotechnology and investment communities. Practicing integrity is imperative to this goal by remaining transparent and practicing honest investment. When companies and leaders of the industry all respect these values for good business and organization, strong alliances can be formed.
OpusPoint Partners is creating relationships with several researchers, investors and corporations that have the same goals while helping new companies to meet their priority goals. These partnerships are part of the larger aim to offer the world new innovations that will affect how diseases are diagnosed and treated. Along with this team, Dr. Lindsay Rosenwald and OpusPoint Partners will seek out and invest in companies promising breakthrough medical research.
Dr. Lindsay Rosenwald and OpusPoint Partners are really pushing the boundaries of biotech investing. They are changing and improving the standards of investing. The advice they give to biotechnical facilities is to apply well-rounded business practices and a strong set of principles. With these applications, companies can benefit from gaining high returns without high risks. The success of OpusPoint Partners proves that this formula works.
And Dr. Rosenwald is not new to success. He has had a wealth of experience. He has had over 17 years on Wall Street as a biotechnology entrepreneur. He has also played a big role in the founding and recapitalization of several biotech and life sciences companies, both public and private. He holds a B.S. in Finance from Pennsylvania State University and an M.D. from the Temple University School of Medicine.
He also has solid financial experience managing billions of dollars in funds. He managed the Aries Funds from 1994 to 2007 and the Orion Fund from 2002 to 2006. The Aries Funds have invested more than $1 billion in healthcare. The Orion Fund, on the other hand, is completely for private biotechnology investing, particularly PIPEs.
OpusPoint Partners is founded upon a bold mission – to establish a strong network of life science and healthcare groups that are committed to honesty and integrity. This is a rarity in today’s world where business leaders often disregard ethics in order to get desired clinical trial results and more profit.
OpusPoint Partners intends to be a diversion from that commonality. The company has shown a great deal of integrity in dealings with shareholders, investors and employees. And a valued approach of ethical standards is used in handling the matters of testing, manufacturing and investigating drugs.
Under Michael Weiss and Dr. Lindsay Rosenwald’s leadership, OpusPoint Partners has a promising future. With the shared experience and knowledge both leaders possess, the company is bound to play a crucial role in revolutionizing medicine and healthcare.
It is difficult, though, to change practices that have been the basis of medical approaches for years. It will take money, time, energy and strong commitment to keep within the guiding lines of ethics and to resist going to any means just to reap more profits.
Dr. Rosenwald, however, thinks this can be done. As an example, he points out the achievements the company has already made. Over the last several years, OpusPoint Partners has already surpassed projected goals while they assisted the financing of over 20 companies. Using the best kind of practices and processes will most certainly yield rewards in drug research and finance.
Dr. Lindsay Rosenwald serves on the Board of Directors of the Republican Jewish Coalition. He has also made strong connections with industry leaders from the biotechnology financing sector. OpusPoint Partners looks forward to a successful future under his leadership.
Related posts:
- OpusPoint Partners: Changing the Face of Life Science and Healthcare
- Lindsay Rosenwald Investing in Future ofLife Sciences and Healthcare
- Lindsay Rosenwald A Step Ahead In Investment Of Healthcare & Lifescience
- Dr. Lindsay Rosenwald – The Success Story
- Dr. Lindsay Rosenwald – The Most Prolific Leader